{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19333864", "DateCompleted": {"Year": "2009", "Month": "06", "Day": "04"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "2040-3437", "JournalIssue": {"Volume": "12", "Issue": "2", "PubDate": {"Year": "2009", "Month": "Mar"}}, "Title": "Current opinion in drug discovery & development", "ISOAbbreviation": "Curr Opin Drug Discov Devel"}, "ArticleTitle": "Discovery of natural product anticancer agents from biodiverse organisms.", "Pagination": {"StartPage": "189", "EndPage": "196", "MedlinePgn": "189-96"}, "Abstract": {"AbstractText": ["Since the early 1960s, small organic molecules derived naturally from microbes and plants have provided a number of useful cancer chemotherapeutic drugs. The search for naturally occurring lead compounds of this type has continued in recent years, with the constituents of marine fauna and flora as well as those of terrestrial microorganisms and plants being investigated for their anticancer activities. In the present short review, selected novel compounds that have been obtained from organisms of diverse biological origin, or their derivatives, are discussed in terms of their potential use as cancer chemotherapeutic agents. Such promising lead compounds tend to generate considerable interest among scientists such as synthetic organic chemists and biologists. Consequently, the supply of a given precious natural product sample may be enhanced, and it may be possible to determine a preliminary notion of structure-activity relationships and of its potential mechanism of action."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Medicinal Chemistry & Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. kinghorn.4@osu.edu"}], "Identifier": [], "LastName": "Kinghorn", "ForeName": "A Douglas", "Initials": "AD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chin", "ForeName": "Young-Won", "Initials": "YW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Swanson", "ForeName": "Steven M", "Initials": "SM"}], "GrantList": [{"GrantID": "P01 CA125066", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "P01 CA125066-02", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Curr Opin Drug Discov Devel", "NlmUniqueID": "100887519", "ISSNLinking": "1367-6733"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Biodiversity"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Williams DH, Stone MJ, Hauck PR, Rahman SK. Why are secondary metabolites (natural products) biosynthesized? J Nat Prod. 1989;52(6):1189\u20131208.", "ArticleIdList": ["2693613"]}, {"Citation": "Kinghorn AD. Drug discovery from natural products. In: Lemke TL, Williams DA, editors. Foye\u2019s Principles of Medicinal Chemistry. 6th Edition. Philadelphia, PA, USA: Wolters Kluwer/Williams & Wilkins; 2008. pp. 12\u201325."}, {"Citation": "Cragg GM, Newman DJ. A tale of two tumor targets: Topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy. J Nat Prod. 2004;67(2):232\u2013244.", "ArticleIdList": ["14987065"]}, {"Citation": "Newman DJ, Cragg GM. Marine natural products and related compounds in clinical and advanced preclinical trials. J Nat Prod. 2004;67(8):1216\u20131238.", "ArticleIdList": ["15332835"]}, {"Citation": "Butler MS. Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep. 2008;25(3):475\u2013516.", "ArticleIdList": ["18497896"]}, {"Citation": "Butler MS, Newman DJ. Mother Nature\u2019s gifts to diseases of man: the impact of natural products on anti-infective, anticholestemics and anticancer drug discovery. In: Petersen F, Amstutuz R, editors. Natural Compounds as Drugs, Volume 1. Switzerland: Birkha\u00fcser/Basel; 2008. pp. 3\u201344. (Progress in Drug Research, vol. 65)", "ArticleIdList": ["18084912"]}, {"Citation": "Clardy J, Walsh C. Lessons from natural molecules. Nature (London) 2004;432(7019):829\u2013837.", "ArticleIdList": ["15602548"]}, {"Citation": "Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nature Rev Drug Discov. 2005;4(3):206\u2013220.", "ArticleIdList": ["15729362"]}, {"Citation": "Tan GT, Gyllenhaal C, Soejarto DD. Biodiversity as a source of anticancer agents. Curr. Drug Targets. 2006;7(3):265\u2013277.", "ArticleIdList": ["16515527"]}, {"Citation": "Eyberger AL, Dondapati R, Porter JR. Endophyte fungal isolates from Podophyllum peltatum produce podophyllotoxin. J Nat Prod. 2006;69(8):1121\u20131124.", "ArticleIdList": ["16933860"]}, {"Citation": "Boyd MR, Paull KD. Some practical considerations and applications of the National Institute in vitro anticancer drug discovery screen. Drug Devel Res. 1995;34(2):91\u2013109."}, {"Citation": "Shoemaker RH. The NCI 60 human tumour cell line anticancer drug screen. Nature Rev Cancer. 2006;6(10):813\u2013823.", "ArticleIdList": ["16990858"]}, {"Citation": "Zhou B-N, Hoch JM, Johnson RK, Mattern MR, Eng W-K, Ma J, Hecht SM, Newman DJ, Kingston DGI. Use of COMPARE analysis to discover new natural product drugs: Isolation of camptothecin and 9-methoxycamptothecin from a new source. J Nat Prod. 2000;63(9):1273\u20131276.", "ArticleIdList": ["11000035"]}, {"Citation": "Casciari JJ, Hollingshead MG, Alley MC, Mayo JG, Malspeis L, Miyauchi S, Grever MR, Weinstein JN. Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor model. J Natl Cancer Inst. 1994;86(24):1846\u20131852.", "ArticleIdList": ["7990159"]}, {"Citation": "Hollingshead MG, Alley MC, Camalier RF, Abbott BJ, Mayo JG, Malspeis L, Grever MR. In vivo cultivation of tumor cells in hollow fibers. Life Sci. 1995;57(2):131\u2013141.", "ArticleIdList": ["7603295"]}, {"Citation": "Hall LA, Krauthauser CM, Wexler RS, Hollingshead MG, Slee AM, Kerr JS. The hollow fiber assay: continued characterization with novel approaches. Anticancer Res. 2000;20(2A):903\u2013911.", "ArticleIdList": ["10810375"]}, {"Citation": "Mi Q, Lantvit D, Reyes-Lim E, Chai H, Zhao W, Lee I-S, Peraza-Sanchez S, Ngassapa O, Kardono LBS, Riswan S, Hollingshead MG, Mayo JG, Farnsworth NR, Cordell GA, Kinghorn AD, Pezzuto JM. Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests. J Nat Prod. 2002;65(6):842\u2013850.", "ArticleIdList": ["12088425"]}, {"Citation": "Kinghorn AD, Farnsworth NR, Soejarto DD, Cordell GA, Swanson SM, Pezzuto JM, Wani MC, Wall ME, Oberlies NC, Kroll DJ, Kramer RA, Rose WC, Vite GD, Fairchild CR, Peterson RW, Wild R. Novel strategies for the discovery of plant-derived anticancer agents. Pharm Biol. 2003;41 Suppl:53\u201367."}, {"Citation": "Phifer SS, Lee D, Seo E-K, Kim N-C, Graf TN, Kroll DJ, Navarro HA, Izydore RA, Jimenez F, Garcia R, Rose WC, Fairchild CR, Wild R, Soejarto DD, Farnsworth NR, Kinghorn AD, Oberlies NH, Wall ME, Wani MC. Alvaradoins E-N, antitumor and cytotoxic anthracenone C-glycosides from the leaves of Alvaradoa haitiensis. J Nat Prod. 2007;70(6):954\u2013961.", "ArticleIdList": ["PMC2442713", "17552563"]}, {"Citation": "Mi Q, Lantvit D, Reyes-Lim E, Chai H, Phifer SS, Wani MC, Wall ME, Tan GT, Cordell GA, Farnsworth NR, Kinghorn AD, Pezzuto JM. Apoptotic anticancer effect of alvaradoin E isolated from Alvaradoa haitiensis. Anticancer Res. 2005;25(2A):779\u2013787.", "ArticleIdList": ["15868909"]}, {"Citation": "Harding WW, Henry GE, Lewis PA, Jacobs H, McLean S, Reynolds WF. Alvaradoins A-D. Anthracenone C arabinosides from Alvaradoa jamaicensis. J Nat Prod. 1999;62(1):98\u2013101.", "ArticleIdList": ["9917291"]}, {"Citation": "Youngsaye W, Lowe JT, Pohlki F, Ralifo P, Panek JS. Total synthesis and stereochemical reassignment of (+)-neopeltolide. Angew Chem Int Edit. 2007;46(48):9211\u20139214.", "ArticleIdList": ["18022886"]}, {"Citation": "Custar DW, Zabawa TP, Scheidt KA. Total synthesis and structural revision of the marine macrolide neopeltolide. J Amer Chem Soc. 2008;130(3):804\u2013805.", "ArticleIdList": ["18161979"]}, {"Citation": "Vintonyak VV, Maier ME. Formal total synthesis of neopeltolide. Org Lett. 2008;10(6):1239\u20131242.", "ArticleIdList": ["18302399"]}, {"Citation": "Woo SK, Kwon MS, Lee E. Total synthesis of (+)-neopeltolide by a Prins macrocyclization. Angew Chem Int Edit. 2008;47(17):3242\u20133244.", "ArticleIdList": ["18348147"]}, {"Citation": "Altmann K-H, Carreira EM. Unraveling a molecular target of macrolides. Nature Chem Biol. 2008;4(7):388\u2013389.", "ArticleIdList": ["18560427"]}, {"Citation": "Ulanovskaya OA, Janjic J, Suzuki M, Sabharwal SS, Schumacker PT, Kron SJ, Kozmin SA. Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. Nature Chem Biol. 2008;4(7):418\u2013424.", "ArticleIdList": ["PMC2673112", "18516048"]}, {"Citation": "Lebar MD, Baker BJ. On the stereochemistry of palmerolide A. Tetrahedron Lett. 2007;48(45):8009\u20138010."}, {"Citation": "Jiang X, Liu B, Lebreton S, De Brabander JK. Total synthesis and structure revision of the marine metabolite palmerolide A. J Amer Chem Soc. 2007;129(20):6386\u20136387.", "ArticleIdList": ["PMC2529175", "17458968"]}, {"Citation": "Nicolaou KC, Guduru R, Sun Y-P, Banerji B, Chen DY-K. Total synthesis of the originally proposed and revised structures of palmerolide A. Angew Chem Int Edit. 2007;46(31):5896\u20135900.", "ArticleIdList": ["17600809"]}, {"Citation": "Pettit GR, Gaddamidi V, Herald DL, Singh SB, Cragg GM, Schmidt JM, Boettner FE, Williams M, Sagawa Y. Antineoplastic agents, 120. Pancratium littorale. J Nat Prod. 1986;49(6):995\u20131002.", "ArticleIdList": ["3572427"]}, {"Citation": "Pettit GR, Melody N, Herald DL. Antineoplastic agents. 450. Synthesis of (+)-pancratistatin from (+)-narciclasine as relay(1a) J Org Chem. 2001;66(8):2583\u20132587.", "ArticleIdList": ["11304174"]}, {"Citation": "Kim S, Ko H, Kim E, Kim D. Stereocontrolled total synthesis of pancratistatin. Org Lett. 2002;4(8):1343\u20131345.", "ArticleIdList": ["11950358"]}, {"Citation": "Kekre N, Griffin C, cNulty J, Pandey S. Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemother Pharmacol. 2005;56(1):29\u201338.", "ArticleIdList": ["15726366"]}, {"Citation": "Griffin C, McNulty J, Hamm C, Pandey S. Pancratistatin a novel highly selective anti-cancer agent that induces apoptosis by the activation of membrane-Fas-receptor associated caspase-3. In: Zhang CL, editor. Cell Apoptosis Research Trends. Hauppauge, NY, USA: Nova Science Publishers Inc; 2007. pp. 93\u2013109."}, {"Citation": "Pettit GR, Melody N, Herald DL. Antineoplastic agents. 511. Direct phosphorylation of phenpanstatin and pancratistatin. J Nat Prod. 2004;67(3):322\u2013327.", "ArticleIdList": ["15043403"]}, {"Citation": "Numata A, Iritani M, Yamada T, Minoura K, Matsumura E, Yamori T, Tsuruo T. Novel antitumor metabolites produced by a fungal strain from a sea hare. Tetrahedron Lett. 1997;38(47):8215\u20138218."}, {"Citation": "Yamada T, Iritani M, Ohishi H, Tanaka K, Minoura K, Doi M, Numata A. Pericosines, antitumour metabolites from the sea hare-derived fungus Periconia byssoides. Structures and biological activities. Org Biomolec Chem. 2007;5(24):3979\u20133986.", "ArticleIdList": ["18043803"]}, {"Citation": "Usami Y, Horibe Y, Takaoka I, Ichikawa H, Arimoto M. First total synthesis of (\u2212)- pericosine A from (\u2212)-shikimic acid: structure revision and determination of the absolute configuration of antitumor natural product pericosine A. Synlett. 2006;(10):1598\u20131600."}, {"Citation": "Usami Y, Ueda Y. Stereoselective syntheses of diastereomers of antitumor natural product pericosine A from (\u2212)-quinic acid. Synthesis. 2007;(20):3219\u20133225."}, {"Citation": "Usami Y, Takaoka I, Ichikawa H, Horibe Y, Tomiyama S, Ohtsuka M, Imanishi Y, Arimoto M. First total synthesis of antitumor natural product (+)- and (\u2212)- pericosine A: determination of absolute stereo structure. J Org Chem. 2007;72(16):6127\u20136134.", "ArticleIdList": ["17628106"]}, {"Citation": "Proksch P, Edrada R-A, Ebel R, Bohnenstengel FI, Nugroho BW. Chemistry and biological activity of rocaglamide derivatives and related compounds in Aglaia species (Meliaceae) Curr Org Chem. 2001;5(9):923\u2013938."}, {"Citation": "Kim S, Salim AA, Swanson SM, Kinghorn AD. Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy. Anti-Cancer Agents Med Chem. 2006;6(4):319\u2013345.", "ArticleIdList": ["16842234"]}, {"Citation": "Ohse T, Ohba S, Yamamoto T, Koyano T, Umezawa K. Cyclopentabenzofuran lignan protein synthesis inhibitors from Aglaia odorata. J Nat Prod. 1996;59(7):650\u2013652.", "ArticleIdList": ["8759160"]}, {"Citation": "Bohnenstengel FI, Steube KG, Meyer C, Quentmeier H, Nugroho BW, Proksch P. 1H- cyclopenta[b]benzofuran lignans from Aglaia species inhibit cell proliferation and alter cell cycle distribution in human monocytic leukemia cell lines. Z Naturforsch [C] 1999;54(12):1075\u20131083.", "ArticleIdList": ["10685499"]}, {"Citation": "Lee SK, Cui B, Mehta RR, Kinghorn AD, Pezzuto JM. Cytostatic mechanism and antitumor potential of novel 1H-cyclopenta[b]benzofuran lignans isolated from Aglaia elliptica. Chem-Biol Interact. 1998;115(3):215\u2013228.", "ArticleIdList": ["9851291"]}, {"Citation": "Baumann B, Bohnenstengel F, Siegmund D, Wajant H, Weber C, Herr I, Debatin KM, Proksch P, Wirth T. Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells. J Biol Chem. 2002;277(47):44791\u201344800.", "ArticleIdList": ["12237314"]}, {"Citation": "Hwang BY, Su B-N, Chai H, Mi Q, Kardono LBS, Afriastini JJ, Riswan S, Santarsiero BD, Mesecar AD, Wild R, Fairchild CR, Vite GD, Rose WC, Farnsworth NR, Cordell GA, Pezzuto JM, Swanson SM, Kinghorn AD. Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. J Org Chem. 2004;69(10):3350\u20133358. [Erratum: J Org Chem (2004) 69(18):6156]", "ArticleIdList": ["15132542"]}, {"Citation": "Meurer-Grimes BM, Yu J, Vairo GL. Therapeutic compounds and methods. PCT Int. Appl. 2002:60. WO 2002002566 A1 20020110."}, {"Citation": "Gerard B, Cencic R, Pelletier J, Porco JA. Enantioselective synthesis of the complex rocaglate (\u2212)-silvestrol. Angew Chem Int Edit. 2007;46(41):7831\u20137834.", "ArticleIdList": ["17806093"]}, {"Citation": "El Sous M, Khoo ML, Holloway G, Owen D, Scammells PJ, Rizzacasa MA. Total synthesis of (\u2212)-episilvestrol and (\u2212)-silvestrol. Angew Chem Int Edit. 2007;46(41):7835\u20137838.", "ArticleIdList": ["17823902"]}, {"Citation": "Mi Q, Kim S, Hwang BY, Su B-N, Chai H, Arbieva ZH, Kinghorn AD, Swanson SM. Silvestrol regulates G2/M checkpoint genes independent of p53 activity. Anticancer Res. 2006;26(5A):3349\u20133356.", "ArticleIdList": ["17094452"]}, {"Citation": "Kim S, Hwang BY, Su B-N, Chai H, Mi Q, Kinghorn AD, Wild R, Swanson SM. Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or \u22127. Anticancer Res. 2007;27(4B):2175\u20132183.", "ArticleIdList": ["PMC2787233", "17695501"]}, {"Citation": "Bordeleau ME, Robert F, Gerard B, Lindqvist L, Chen SM, Wendel HG, Brem B, Greger H, Lowe SW, Porco JA, Pelletier J. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Invest. 2008 doi:101172/JCI34753.", "ArticleIdList": ["PMC2423864", "18551192"]}, {"Citation": "Edwards RB, Lucas DM, Lozanski G, Johnson AJ, Su B-N, Lin TS, Byrd JC, Kinghorn AD, Grever MR. Silvestrol, a rocaglate derivative from Aglaia foveolata, has significant Bcl-1 and p53-independent antitumor activity against chronic lymphocytic leukemia cells in vitro.; 48th Annual Meeting of the American Society of Hematology; Orlando, FL. 2006. Dec 9\u201312,"}, {"Citation": "Edwards RB, Lucas DM, West DA, De Lay MD, Lozanski G, Johnson AJ, Salim AA, Lin TS, Byrd JC, Kinghorn AD, Grever MR. The plant-derived agent silvestrol has B-cell selective activity in vitro in chronic lymphocytic leukemia patient cells and in vivo in the Tcl-1 mouse model of CLL; 49th Annual Meeting of the American Society of Hematology; Atlanta, GA: 2007. Dec 8\u201311,"}, {"Citation": "Salim AA, Chai H-B, Rachman I, Riswan S, Kardono LBS, Farnsworth NR, Carcache-Blanco EJ, Kinghorn AD. Constituents of the leaves and stem bark of Aglaia foveolata. Tetrahedron. 2007;63(33):7926\u20137934.", "ArticleIdList": ["PMC2034361", "18698338"]}, {"Citation": "Masuoka Y, Nagai A, Shin-ya K, Furihata K, Nagai K, Suzuki K-I, Hayakawa Y, Seto H. Spiruchostatins A and B, novel gene expression-enhancing substances produced by Pseudomonas sp. Tetrahedron Lett. 2001;42(1):41\u201344."}, {"Citation": "Townsend PA, Crabb SJ, Davidson SM, Johnson PWM, Packham G, Ganesan A. The bicyclic depsipeptide family of histone deacetylase inhibitors. Chem Biol. 2007;2:693\u2013720."}, {"Citation": "Yurek-George A, Habens F, Brimmell M, Packham G, Ganesan A. Total synthesis of spiruchostatin A, a potent histone deacetylase inhibitor. J Amer Chem Soc. 2004;126(4):1030\u20131031.", "ArticleIdList": ["14746465"]}, {"Citation": "Doi T, Iijima Y, Shin-Ya K, Ganesan A, Takahashi T. A total synthesis of spiruchostatin A. Tetrahedron Lett. 2006;47(7):1177\u20131180."}, {"Citation": "Takizawa T, Watanabe K, Narita K, Oguchi T, Abe H, Katoh T. Total synthesis of spiruchostatin B, a potent histone deacetylase inhibitor, from a microorganism. Chem Commun. 2008;(14):1677\u20131679.", "ArticleIdList": ["18368162"]}, {"Citation": "Shindoh N, Mori M, Terada Y, Oda K, Amino N, Kita A, Taniguchi M, Sohda K-Y, Nagai K, Sowa Y, Masuoka Y, Orita M, Sasamata M, Matsushime H, Furuichi K, Sakai T. YM753, a novel histone deacetylase inhibitor, exhibits antitumor activity with selective, sustained accumulation of acetylated histones in tumors in the WiDr xenograft model. Int J Oncol. 2008;32(3):545\u2013555.", "ArticleIdList": ["18292931"]}]}], "History": [{"Year": "2009", "Month": "4", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "4", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "6", "Day": "6", "Hour": "9", "Minute": "0"}, {"Year": "2010", "Month": "5", "Day": "27"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19333864", "NIHMS201363", "PMC2877274"]}}], "PubmedBookArticle": []}